BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, van den Pol AN. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 2006;26:13037-47. [PMID: 17167093 DOI: 10.1523/JNEUROSCI.3380-06.2006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Linehan V, Hirasawa M. Short-term fasting induces alternate activation of orexin and melanin-concentrating hormone neurons in rats. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.04.006] [Reference Citation Analysis]
2 Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35. [PMID: 19723027 DOI: 10.1111/j.1748-1716.2009.02036.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
3 Latifi B, Adamantidis A, Bassetti C, Schmidt MH. Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Front Neurol 2018;9:790. [PMID: 30344503 DOI: 10.3389/fneur.2018.00790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
4 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2015;172:334-48. [PMID: 24641197 DOI: 10.1111/bph.12639] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 12.1] [Reference Citation Analysis]
5 Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence. Neuropsychopharmacology 2018;43:1010-20. [PMID: 29052613 DOI: 10.1038/npp.2017.250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
6 Schmeichel BE, Matzeu A, Koebel P, Vendruscolo LF, Sidhu H, Shahryari R, Kieffer BL, Koob GF, Martin-Fardon R, Contet C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 2018;43:2373-82. [PMID: 29703996 DOI: 10.1038/s41386-018-0054-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
7 Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res 2018;7:F1000 Faculty Rev-1421. [PMID: 30254737 DOI: 10.12688/f1000research.15097.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
8 Li X, Marchant NJ, Shaham Y. Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation. Proc Natl Acad Sci U S A 2014;111:5765-6. [PMID: 24706899 DOI: 10.1073/pnas.1403603111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
9 Mickelsen LE, Kolling FW 4th, Chimileski BR, Fujita A, Norris C, Chen K, Nelson CE, Jackson AC. Neurochemical Heterogeneity Among Lateral Hypothalamic Hypocretin/Orexin and Melanin-Concentrating Hormone Neurons Identified Through Single-Cell Gene Expression Analysis. eNeuro 2017;4:ENEURO. [PMID: 28966976 DOI: 10.1523/ENEURO.0013-17.2017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 9.6] [Reference Citation Analysis]
10 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
11 Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
12 Aso Y, Ray RP, Long X, Bushey D, Cichewicz K, Ngo TT, Sharp B, Christoforou C, Hu A, Lemire AL, Tillberg P, Hirsh J, Litwin-Kumar A, Rubin GM. Nitric oxide acts as a cotransmitter in a subset of dopaminergic neurons to diversify memory dynamics. Elife 2019;8:e49257. [PMID: 31724947 DOI: 10.7554/eLife.49257] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 9.7] [Reference Citation Analysis]
13 Lindberg J, Saetre P, Nishino S, Mignot E, Jazin E. Reduced expression of TAC1, PENK and SOCS2 in Hcrtr-2 mutated narcoleptic dog brain. BMC Neurosci 2007;8:34. [PMID: 17521418 DOI: 10.1186/1471-2202-8-34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
14 Branch AF, Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. Sleep 2016;39:369-77. [PMID: 26446125 DOI: 10.5665/sleep.5446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
15 Thomas TS, Baimel C, Borgland SL. Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations. Br J Pharmacol 2018;175:2825-33. [PMID: 28849596 DOI: 10.1111/bph.13993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
16 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Hara J, Gerashchenko D, Wisor JP, Sakurai T, Xie X, Kilduff TS. Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons. J Neurosci 2009;29:3705-14. [PMID: 19321767 DOI: 10.1523/JNEUROSCI.0431-09.2009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
18 Nusbaum MP, Blitz DM, Marder E. Functional consequences of neuropeptide and small-molecule co-transmission. Nat Rev Neurosci 2017;18:389-403. [PMID: 28592905 DOI: 10.1038/nrn.2017.56] [Cited by in Crossref: 128] [Cited by in F6Publishing: 97] [Article Influence: 25.6] [Reference Citation Analysis]
19 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
20 Simmons SJ, Gentile TA. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect. Brain Res 2020;1731:146164. [PMID: 30796894 DOI: 10.1016/j.brainres.2019.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Apergis-Schoute J, Iordanidou P, Faure C, Jego S, Schöne C, Aitta-Aho T, Adamantidis A, Burdakov D. Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits. J Neurosci 2015;35:5435-41. [PMID: 25855162 DOI: 10.1523/JNEUROSCI.5269-14.2015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 52] [Article Influence: 11.3] [Reference Citation Analysis]
22 Parsons MP, Burt J, Cranford A, Alberto C, Zipperlen K, Hirasawa M. Nociceptin induces hypophagia in the perifornical and lateral hypothalamic area. PLoS One 2012;7:e45350. [PMID: 23028954 DOI: 10.1371/journal.pone.0045350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
23 Lee J, Raycraft L, Johnson AW. The dynamic regulation of appetitive behavior through lateral hypothalamic orexin and melanin concentrating hormone expressing cells. Physiol Behav 2021;229:113234. [PMID: 33130035 DOI: 10.1016/j.physbeh.2020.113234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Oh J, Petersen C, Walsh CM, Bittencourt JC, Neylan TC, Grinberg LT. The role of co-neurotransmitters in sleep and wake regulation. Mol Psychiatry 2019;24:1284-95. [PMID: 30377299 DOI: 10.1038/s41380-018-0291-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
25 Ferrari LL, Park D, Zhu L, Palmer MR, Broadhurst RY, Arrigoni E. Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons. J Neurosci 2018;38:1588-99. [PMID: 29311142 DOI: 10.1523/JNEUROSCI.1925-17.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
26 Zhou WL, Gao XB, Picciotto MR. Acetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms.. eNeuro 2015;2:e0052. [PMID: 26322330 DOI: 10.1523/ENEURO.0052-14.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
27 Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 2007;27:4870-81. [PMID: 17475795 DOI: 10.1523/JNEUROSCI.0732-07.2007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
28 Morin LP. A Path to Sleep Is through the Eye. eNeuro 2015;2:ENEURO. [PMID: 26464977 DOI: 10.1523/ENEURO.0069-14.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Parks GS, Wang L, Wang Z, Civelli O. Identification of neuropeptide receptors expressed by melanin-concentrating hormone neurons. J Comp Neurol 2014;522:3817-33. [PMID: 24978951 DOI: 10.1002/cne.23642] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
30 Schöne C, Burdakov D. Glutamate and GABA as rapid effectors of hypothalamic "peptidergic" neurons. Front Behav Neurosci 2012;6:81. [PMID: 23189047 DOI: 10.3389/fnbeh.2012.00081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
31 Arrigoni E, Saper CB. What optogenetic stimulation is telling us (and failing to tell us) about fast neurotransmitters and neuromodulators in brain circuits for wake-sleep regulation. Curr Opin Neurobiol 2014;29:165-71. [PMID: 25064179 DOI: 10.1016/j.conb.2014.07.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
32 Schöne C, Cao ZF, Apergis-Schoute J, Adamantidis A, Sakurai T, Burdakov D. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J Neurosci 2012;32:12437-43. [PMID: 22956835 DOI: 10.1523/JNEUROSCI.0706-12.2012] [Cited by in Crossref: 95] [Cited by in F6Publishing: 66] [Article Influence: 9.5] [Reference Citation Analysis]
33 Martin-Fardon R, Cauvi G, Kerr TM, Weiss F. Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict Biol 2018;23:6-15. [PMID: 27558790 DOI: 10.1111/adb.12441] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
34 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
35 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
36 Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF. Opioids in the perifornical lateral hypothalamus suppress ethanol drinking. Alcohol 2013;47:31-8. [PMID: 23199698 DOI: 10.1016/j.alcohol.2012.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
37 Li N, Nattie E, Li A. The role of melanin concentrating hormone (MCH) in the central chemoreflex: a knockdown study by siRNA in the lateral hypothalamus in rats. PLoS One 2014;9:e103585. [PMID: 25084113 DOI: 10.1371/journal.pone.0103585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
38 Liu JJ, Mirabella VR, Pang ZP. Cell type- and pathway-specific synaptic regulation of orexin neurocircuitry. Brain Res 2020;1731:145974. [PMID: 30296428 DOI: 10.1016/j.brainres.2018.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Ferrari LL, Agostinelli LJ, Krashes MJ, Lowell BB, Scammell TE, Arrigoni E. Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms. J Physiol 2016;594:1069-85. [PMID: 26613645 DOI: 10.1113/JP271657] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
40 Zhou Y, Cui CL, Schlussman SD, Choi JC, Ho A, Han JS, Kreek MJ. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience 2008;153:1225-34. [PMID: 18436386 DOI: 10.1016/j.neuroscience.2008.03.023] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
41 Diniz GB, Bittencourt JC. The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated Behaviors. Front Syst Neurosci 2017;11:32. [PMID: 28611599 DOI: 10.3389/fnsys.2017.00032] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
42 Mosqueiro T, de Lecea L, Huerta R. Control of sleep-to-wake transitions via fast aminoacid and slow neuropeptide transmission. New J Phys 2014;16:115010. [PMID: 25598695 DOI: 10.1088/1367-2630/16/11/115010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
43 Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I. Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology 2010;35:752-63. [PMID: 19924112 DOI: 10.1038/npp.2009.183] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 7.8] [Reference Citation Analysis]
44 Burdakov D, González JA. Physiological functions of glucose-inhibited neurones. Acta Physiol (Oxf) 2009;195:71-8. [PMID: 18983451 DOI: 10.1111/j.1748-1716.2008.01922.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
45 van den Pol AN. Neuropeptide transmission in brain circuits. Neuron 2012;76:98-115. [PMID: 23040809 DOI: 10.1016/j.neuron.2012.09.014] [Cited by in Crossref: 350] [Cited by in F6Publishing: 332] [Article Influence: 35.0] [Reference Citation Analysis]
46 Thomas CS, Mohammadkhani A, Rana M, Qiao M, Baimel C, Borgland SL. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours. Neuropsychopharmacology 2021. [PMID: 34663867 DOI: 10.1038/s41386-021-01196-y] [Reference Citation Analysis]
47 Chowdhury S, Hung CJ, Izawa S, Inutsuka A, Kawamura M, Kawashima T, Bito H, Imayoshi I, Abe M, Sakimura K, Yamanaka A. Dissociating orexin-dependent and -independent functions of orexin neurons using novel Orexin-Flp knock-in mice. Elife 2019;8:e44927. [PMID: 31159922 DOI: 10.7554/eLife.44927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
48 Li Y, van den Pol AN. Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. J Neurosci 2008;28:2814-9. [PMID: 18337411 DOI: 10.1523/JNEUROSCI.5447-07.2008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
49 Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences 2014;111:E1648-55. [DOI: 10.1073/pnas.1315542111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 19.9] [Reference Citation Analysis]
50 Zhang X, van den Pol AN. Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin. J Physiol 2013;591:1731-47. [PMID: 23318874 DOI: 10.1113/jphysiol.2012.248385] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
51 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
52 Villano I, Messina A, Valenzano A, Moscatelli F, Esposito T, Monda V, Esposito M, Precenzano F, Carotenuto M, Viggiano A. Basal Forebrain Cholinergic System and Orexin Neurons: Effects on Attention. Front Behav Neurosci. 2017;11:10. [PMID: 28197081 DOI: 10.3389/fnbeh.2017.00010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
53 Matzeu A, Martin-Fardon R. Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus. Front Neurol 2018;9:720. [PMID: 30210441 DOI: 10.3389/fneur.2018.00720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
54 Castro DC, Berridge KC. Advances in the neurobiological bases for food 'liking' versus 'wanting'. Physiol Behav 2014;136:22-30. [PMID: 24874776 DOI: 10.1016/j.physbeh.2014.05.022] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 11.4] [Reference Citation Analysis]
55 Song Y, Li J, Li H, Cai M, Miao D. The role of ventral tegmental area orexinergic afferents in depressive-like behavior in a chronic unpredictable mild stress (CUMS) mouse model. Biochem Biophys Res Commun 2021;579:22-8. [PMID: 34583191 DOI: 10.1016/j.bbrc.2021.09.062] [Reference Citation Analysis]
56 Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103. [PMID: 18417630 DOI: 10.1152/jn.01243.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
57 Hayatdavoudi P, Sadeghnia HR, Mohamadian-Roshan N, Hadjzadeh MA. Beneficial Effects of Selective Orexin-A Receptor Antagonist in 4-aminopyridine-induced Seizures in Male Rats. Adv Biomed Res 2017;6:162. [PMID: 29387673 DOI: 10.4103/abr.abr_262_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Concetti C, Burdakov D. Orexin/Hypocretin and MCH Neurons: Cognitive and Motor Roles Beyond Arousal. Front Neurosci 2021;15:639313. [PMID: 33828450 DOI: 10.3389/fnins.2021.639313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Bruchas MR, Land BB, Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 2010;1314:44-55. [PMID: 19716811 DOI: 10.1016/j.brainres.2009.08.062] [Cited by in Crossref: 305] [Cited by in F6Publishing: 301] [Article Influence: 23.5] [Reference Citation Analysis]
60 Schlegel P, Texada MJ, Miroschnikow A, Schoofs A, Hückesfeld S, Peters M, Schneider-Mizell CM, Lacin H, Li F, Fetter RD, Truman JW, Cardona A, Pankratz MJ. Synaptic transmission parallels neuromodulation in a central food-intake circuit. Elife 2016;5:e16799. [PMID: 27845623 DOI: 10.7554/eLife.16799] [Cited by in Crossref: 75] [Cited by in F6Publishing: 41] [Article Influence: 12.5] [Reference Citation Analysis]
61 Anderson RI, Moorman DE, Becker HC. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol. Handb Exp Pharmacol 2018;248:473-503. [PMID: 29526023 DOI: 10.1007/164_2018_100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Zhang XY, Yu L, Zhuang QX, Zhu JN, Wang JJ. Central functions of the orexinergic system. Neurosci Bull 2013;29:355-65. [PMID: 23299718 DOI: 10.1007/s12264-012-1297-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
63 Kosse C, Burdakov D. A unifying computational framework for stability and flexibility of arousal. Front Syst Neurosci 2014;8:192. [PMID: 25368557 DOI: 10.3389/fnsys.2014.00192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]